Evelo Biosciences Inc
(OTCPK:EVLO)
$
0.0005
0 (0%)
Market Cap: 9,000.00
Enterprise Value: 16.70 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 Evelo Biosciences Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019 / 02:35PM GMT
Release Date Price:
$129.6
(-0.77%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director
Good. So thanks, everybody. We're going to get started with the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly before we get going, I need to read a disclosure statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk. So very pleased to have the team from Evelo here.
Balkrishan Gill
Evelo Biosciences, Inc. - President, CEO & Director
Thank you.
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director
Simba, I don't know if you want to make any opening comments. If not, we'll jump right in, but...
Balkrishan Gill
Evelo Biosciences, Inc. - President, CEO & Director
Jump straight in.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot